These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18953696)

  • 1. . . . and recommending an ECG starting stimulant medicines in kids.
    Child Health Alert; 2008 Sep; 26():2-3. PubMed ID: 18953696
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications.
    Thomas PE; Carlo WF; Decker JA; Cannon BC; Kertesz NJ; Friedman RA; Kim JJ
    Arch Pediatr Adolesc Med; 2011 Feb; 165(2):166-70. PubMed ID: 21300657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL; Elia J; Erickson C; Berger S; Blum N; Uzark K; Webb CL; ;
    Circulation; 2008 May; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul; 50(1291):60. PubMed ID: 18654112
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM; Friedman RA; Knilans TK; ;
    Pediatrics; 2008 Aug; 122(2):451-3. PubMed ID: 18676566
    [No Abstract]   [Full Text] [Related]  

  • 7. American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008.
    American Academy of Pediatrics/American Heart Association
    J Dev Behav Pediatr; 2008 Aug; 29(4):335. PubMed ID: 18698199
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH; Donnelly C
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL; Jhung MA; Budnitz DS
    N Engl J Med; 2006 May; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrocardiograms for attention deficit disorder.
    Moodie DS
    Congenit Heart Dis; 2008; 3(5):307. PubMed ID: 18837807
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulants and sudden death: what is a physician to do?
    Wilens TE; Prince JB; Spencer TJ; Biederman J
    Pediatrics; 2006 Sep; 118(3):1215-9. PubMed ID: 16951018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M
    Pediatrics; 2007 Jan; 119(1):154-5. PubMed ID: 17200281
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of growth in stimulant-naive children with attention-deficit/hyperactivity disorder by using cross-sectional and longitudinal approaches.
    Poulton A; Nanan R
    Pediatrics; 2008 Jul; 122(1):221; author reply 221-2. PubMed ID: 18596017
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant use and trichotillomania.
    Martin A; Scahill L; Vitulano L; King RA
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):349-50. PubMed ID: 9549952
    [No Abstract]   [Full Text] [Related]  

  • 17. ADHD drugs and cardiovascular risk.
    Rappley MD; Moore JW; Dokken D
    N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract]   [Full Text] [Related]  

  • 18. Are stimulants overprescribed?
    Perry R; Gilbert EM; Angkustsiri K
    J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269-70; author reply 270-1. PubMed ID: 10714041
    [No Abstract]   [Full Text] [Related]  

  • 19. Survey of United States child and adolescent psychiatrists' cardiac screening practices prior to starting patients on stimulants.
    Leslie LK; Rodday AM; Saunders TS; Cohen JT; Wong JB; Sheldrick RC; Parsons SK
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):375-84. PubMed ID: 23083024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(6):5-7. PubMed ID: 12449103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.